Compositions and methods for regulating glucose homeostasis and insulin action
AssigneeUniversity of Virginia Patent Foundation
InventorsKyle Hoehn, Brandon Kenwood
Life of this patent
Estimating the term…
Loading patent…
AssigneeUniversity of Virginia Patent Foundation
InventorsKyle Hoehn, Brandon Kenwood
Estimating the term…
The present invention encompasses the use of compounds for a novel approach to treat and prevent diseases, conditions, and disorders such as diabetes and ischemic reperfusion injury. Compounds of the invention, including but not limited to BAM15 ((2-fluorophenyl){6-[(2-fluorophenyl)amino](1,2,5-oxadiazolo[3,4-e]pyrazin-5-yl)}amine), a mitochondrial uncoupler, can improve glucose tolerance, increases cellular oxygen consumption, treat or prevent kidney ischemia reperfusion injury reverse insulin resistance, reverse or treat hyperinsulinemia, and reverse or treat hyperlipidemia. The present invention further provides novel compounds as well as methods for identifying compounds with the same or similar properties as BAM15.
A method of increasing oxygen consumption, reducing cellular reactive oxygen species, depolarizing a mitochondrial inner membrane, and increasing oxygen consumption rate without donating electrons to the electron transport chain using a mitochondrial uncoupler, said method comprising contacting a cell or mitochondria with a composition comprising at least one compound having a structure of formula I or formula II:
Dependencies are inferred from the claim text.